The chemical class described as CUG-BP2 Activators encompasses a range of compounds that interact with various cellular signaling pathways that, in turn, have the capacity to regulate the function, stability, or expression of the RNA-binding protein CUG-BP2. These activators function by modulating distinct pathways such as AMPK, which is central to energy balance and can indirectly affect protein translation and stability. Other pathways include the PKA and MAPK/ERK pathways, which can influence the post-translational modification of proteins and thereby impact splicing factors, potentially including CUG-BP2.
Further, activators such as mTOR, PI3K, and Wnt signaling pathway compounds, play crucial roles in cell growth, protein synthesis, and gene expression modulation. By influencing these pathways, the activators can affect the translational regulation activities of CUG-BP2. Similarly, changes in intracellular calcium levels, through the action of calcium ionophores, can impact calcium-dependent signaling cascades, with potential repercussions on CUG-BP2's activity. Additionally, PKC activators and HDAC inhibitors can alter the phosphorylation state of proteins and gene expression patterns, respectively, which may change the functional dynamics of CUG-BP2. Moreover, the JNK pathway is linked with transcriptional control and could influence RNA-binding proteins like CUG-BP2. The NF-κB pathway, often associated with the inflammatory response and cellular stress mechanisms, also presents a possible indirect activation route for CUG-BP2. Lastly, compounds that activate CREB, a transcription factor, could lead to altered expression of genes including those encoding for splicing factors such as CUG-BP2. These chemicals and compounds, therefore, play significant roles in the cellular environment that could affect the behavior of CUG-BP2 through a variety of biochemical mechanisms.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $60.00 $270.00 $350.00 | 48 | |
Activates AMPK, which can modulate cellular energy balance and has downstream effects on protein translation and stability, potentially influencing CUG-BP2 activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Elevates cAMP levels, activating PKA, which can phosphorylate serine/arginine-rich (SR) proteins, possibly affecting splicing factors like CUG-BP2. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Activates MAPK/ERK pathway, which can alter the phosphorylation state of various proteins, potentially altering CUG-BP2 activity. | ||||||
XL-184 free base | 849217-68-1 | sc-364657 sc-364657A | 5 mg 10 mg | $92.00 $204.00 | 1 | |
Activates PI3K, leading to downstream activation of AKT, which may influence the stability and function of RNA-binding proteins like CUG-BP2. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $153.00 $520.00 | 4 | |
Activates the Wnt signaling pathway, which could modulate gene expression and protein stability, possibly impacting CUG-BP2. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Increases intracellular calcium levels, which can affect calcium-dependent signaling pathways, potentially influencing CUG-BP2. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates PKC, which can phosphorylate and regulate various proteins, potentially altering the function of splicing factors like CUG-BP2. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Inhibits histone deacetylases, which can affect gene expression patterns, potentially influencing the expression levels of CUG-BP2. | ||||||